Regencell Bioscience Holdings Limited (RGC) Operating cash flow 2019–2025
Regencell Bioscience Holdings Limited (RGC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.1MFY2025 · since FY2019: -$390,990 → -$3.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.1M | +22.2% |
| FY2024 | -$4.0M | +19.4% |
| FY2023 | -$5.0M | +5.8% |
| FY2022 | -$5.3M | -586.4% |
| FY2021 | -$767,311 | -5.6% |
| FY2020 | -$726,573 | -85.8% |
| FY2019 | -$390,990 | — |
Source: SEC XBRL filings · For reference only · Not investment advice